GlassScriptPhysician profile
Niki Momin
NPI 1427724962
$3,172.72
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,307 · 2023: $841 · 2024: $24.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,362.74 | 2022 | |
| Abbvie INC. | $488.65 | 2022-2023 | |
| Amgen INC. | $314.83 | 2022-2023 | Aimovig |
| Lundbeck LLC | $215.74 | 2022-2024 | Vyepti |
| Sk Life Science, INC. | $211.77 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $91.33 | 2023 | Ingrezza, Ongentys |
| Argenx US, INC. | $76.07 | 2022-2023 | Vyvgart Hytrulo, Vyvgart |
| Biohaven Pharmaceutical Holding Company LTD. | $71.13 | 2022 | |
| Csl Behring | $56.23 | 2022 | |
| Alexion Pharmaceuticals, INC. | $45.80 | 2022-2023 | Ultomiris |
| Lilly USA, LLC | $41.78 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $26.28 | 2022 | |
| Acorda Therapeutics, INC | $26.01 | 2023 | Inbrija |
| Mdd US Operations, LLC | $25.22 | 2023 | Gocovri |
| Avion Pharmaceuticals | $24.47 | 2023 | Dhivy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $18.41 | 2023 | Gamunex-C |
| Genzyme Corporation | $18.00 | 2022 | |
| Upsher-Smith Laboratories LLC | $17.98 | 2022 | |
| Neurelis, INC. | $15.23 | 2022 | |
| Kyowa Kirin, INC. | $13.14 | 2023 | Nourianz |
| Acadia Pharmaceuticals INC | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niki Momin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.